" />

Infectious Diseases

Specialists who take on the challenge of complex trials
Infectious diseases have been the one of the most challenging area to deal with because of its rapid spreading and constant mutation of strains like HIV, H1N1, leishmaniasis and others. The need for innovative antibacterials, antivirals and vaccines to address serious global health issues has never been greater, creating significant market opportunities for biopharmaceutical companies developing novel anti-infectives.

New infectious disease (ID) therapies are increasingly difficult to bring to market, due to complex regulatory environments and the difficulty in identifying experienced investigators – especially for serious infections that must be treated in a hospital setting.

The challenges faced in the current area of this therapy are:
  • Seasonal infectious diseases for which complex protocols are prepared and which are difficult to manage
  • Clear interpretation of data is needed to demonstrate the effectiveness of data
  • Regional difference of diseases

SIRO has worked in the infectious disease indications like:
  • Visceral leishmaniasis
  • HIV
  • Bacterial sinusitis
  • Nosocomial pneumonia
  • And others

The spread of infectious diseases is a threat to the population. SIRO offers reliable access to patients worldwide, applies deep therapeutic experience and global resources to streamline the development process from clinical through post-approval.

Additional Resources
Case Studies:
Infectious diseases case studies